Bruker (BRKR) closed at $66.54 on November 9, 2026, up 8.5% from the previous close, on volume of 2,574,112 shares (30-day average 2,320,736).
Data as of November 9, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 3, 2026 | Strangle or Risk Reversal | 20-Nov-2655 P : 65 C | 2,002 |
| 2-2 | The next 1 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 9, 2026. See the 10 largest for 30, 60 and 90 days
Bruker Completes Reorganization and Updates Segment Reporting
TipRanks (Thu, 5-Nov 5:02 PM ET)
TipRanks (Thu, 5-Nov 10:20 AM ET)
Leerink Partners Sticks to Its Buy Rating for Bruker (BRKR)
TipRanks (Thu, 5-Nov 9:30 AM ET)
TipRanks (Thu, 5-Nov 7:20 AM ET)
Barclays Sticks to Its Buy Rating for Bruker (BRKR)
TipRanks (Thu, 5-Nov 3:37 AM ET)
Bruker Reports Third Quarter 2026 Financial Results
Business Wire (Wed, 4-Nov 7:00 AM ET)
Bruker Sets Nov. 4 Q3 2026 Earnings Webcast, With Pre-Registration and Replay Through Dec. 4
Market Chameleon (Wed, 21-Oct 7:27 AM ET)
Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and Webcast
Business Wire (Tue, 20-Oct 4:01 PM ET)
Business Wire (Tue, 6-Oct 7:00 AM ET)
Business Wire (Mon, 28-Sep 7:00 AM ET)
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Bruker trades on the NASDAQ stock market under the symbol BRKR.
As of November 10, 2026, BRKR stock price declined to $63.18 with 553,785 million shares trading.
BRKR has a beta of 0.92, meaning it tends to be less sensitive to market movements. BRKR has a correlation of 0.04 to the broad based SPY ETF.
BRKR has a market cap of $9.65 billion. This is considered a Mid Cap stock.
Last quarter Bruker reported $874 million in Revenue and $.56 earnings per share. This fell short of revenue expectation by $-866 million and exceeded earnings estimates by $.14.
In the last 3 years, BRKR traded as high as $94.86 and as low as $28.53.
The top ETF exchange traded funds that BRKR belongs to (by Net Assets): IJH, VTI, VB, FBT, VBR.
BRKR has outperformed the market in the last year with a price return of +58.7% while the SPY ETF gained +12.4%. BRKR has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +18.4% and +8.5%, respectively, while the SPY returned -3.2% and -2.4%, respectively.
BRKR support price is $64.21 and resistance is $68.87 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BRKR shares will trade within this expected range on the day.
